151 related articles for article (PubMed ID: 24369888)
21. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.
Suzuki M; Kato I; Aihara T; Hiratsuka J; Yoshimura K; Niimi M; Kimura Y; Ariyoshi Y; Haginomori S; Sakurai Y; Kinashi Y; Masunaga S; Fukushima M; Ono K; Maruhashi A
J Radiat Res; 2014 Jan; 55(1):146-53. PubMed ID: 23955053
[TBL] [Abstract][Full Text] [Related]
22. Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
Kanno H; Nagata H; Ishiguro A; Tsuzuranuki S; Nakano S; Nonaka T; Kiyohara K; Kimura T; Sugawara A; Okazaki Y; Takae S; Nakabayashi T; Arai H; Suzuki H
Oncologist; 2021 Jul; 26(7):e1250-e1255. PubMed ID: 33928712
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck.
Aihara T; Morita N; Kamitani N; Kumada H; Ono K; Hiratsuka J; Harada T
Int J Clin Oncol; 2014; 19(3):437-44. PubMed ID: 23797210
[TBL] [Abstract][Full Text] [Related]
24. [Boron neutron capture therapy (BNCT) for malignant glioma-present status and the points at issue].
Kageji T; Nagahiro S; Toi H; Mizobuchi Y; Nakagawa Y
Nihon Rinsho; 2005 Sep; 63 Suppl 9():442-6. PubMed ID: 16201561
[No Abstract] [Full Text] [Related]
25. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
26. Assessment of dose rate scaling factors used in NCTPlan treatment planning code for the BNCT beam of THOR.
Hsu FY; Liu MT; Tung CJ; Hsueh Liu YW; Chang CC; Liu HM; Chou FI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S130-3. PubMed ID: 19375926
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies.
Kato I; Fujita Y; Maruhashi A; Kumada H; Ohmae M; Kirihata M; Imahori Y; Suzuki M; Sakrai Y; Sumi T; Iwai S; Nakazawa M; Murata I; Miyamaru H; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S37-42. PubMed ID: 19409799
[TBL] [Abstract][Full Text] [Related]
28. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.
Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K
Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175
[TBL] [Abstract][Full Text] [Related]
29. Fatal carotid blowout syndrome after BNCT for head and neck cancers.
Aihara T; Hiratsuka J; Ishikawa H; Kumada H; Ohnishi K; Kamitani N; Suzuki M; Sakurai H; Harada T
Appl Radiat Isot; 2015 Dec; 106():202-6. PubMed ID: 26282568
[TBL] [Abstract][Full Text] [Related]
30. Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real-world experiences over a 2-year period.
Takeno S; Yoshino Y; Aihara T; Higashino M; Kanai Y; Hu N; Kakino R; Kawata R; Nihei K; Ono K
Cancer Med; 2024 Jun; 13(11):e7250. PubMed ID: 38826090
[TBL] [Abstract][Full Text] [Related]
31. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
32. Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.
Monti Hughes A; Pozzi EC; Heber EM; Thorp S; Miller M; Itoiz ME; Aromando RF; Molinari AJ; Garabalino MA; Nigg DW; Trivillin VA; Schwint AE
Oral Oncol; 2011 Nov; 47(11):1017-22. PubMed ID: 21840244
[TBL] [Abstract][Full Text] [Related]
33. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
[TBL] [Abstract][Full Text] [Related]
34. Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study.
Hirose K; Sato M; Kato T; Takayama K; Suzuki M; Yamaguchi H; Seto I; Kikuchi Y; Murakami M; Takai Y
J Radiat Res; 2022 May; 63(3):393-401. PubMed ID: 35388879
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of the new THOR epithermal neutron beam for BNCT.
Tung CJ; Wang YL; Hsu FY; Chang SL; Liu YW
Appl Radiat Isot; 2004 Nov; 61(5):861-4. PubMed ID: 15308158
[TBL] [Abstract][Full Text] [Related]
37. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
38. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
39. Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion.
Yanagie H; Higashi S; Seguchi K; Ikushima I; Fujihara M; Nonaka Y; Oyama K; Maruyama S; Hatae R; Suzuki M; Masunaga S; Kinashi T; Sakurai Y; Tanaka H; Kondo N; Narabayashi M; Kajiyama T; Maruhashi A; Ono K; Nakajima J; Ono M; Takahashi H; Eriguchi M
Appl Radiat Isot; 2014 Jun; 88():32-7. PubMed ID: 24559940
[TBL] [Abstract][Full Text] [Related]
40. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
